Search
Inactivated SARS-CoV-2 Vaccine (Chinese Academy of Medical Sciences)
go.drugbank.com/drugs/DB15863ExperimentalAs of June, 2020, safety and Immunogenicity trials are currently underway for this vaccine (NCT04470609 & NCT04412538). … This vaccine specifically was developed in collaboration with the Chinese Academy of Medical Sciences, West China Second University Hospital, and Yunan Center for Disease Control and Prevention.
Hexamethonium
go.drugbank.com/drugs/DB08960ExperimentalIt has been used for a variety of therapeutic purposes including hypertension but, like the other ganglionic blockers, it has been replaced by more specific drugs for most purposes, although it is widely
D-JNKI-1
go.drugbank.com/drugs/DB05660InvestigationalA synthetic, cell permeable peptide that blocks the MAPK-JNK signal pathway; has potential therapeutic value for long-term protection of both the morphological integrity and physiological function of the
ORG-34517
go.drugbank.com/drugs/DB05423InvestigationalORG-34517 is currently under investigation by Organon for the treatment of depression.
Pecilocin
go.drugbank.com/drugs/DB13459ExperimentalCategories: Antifungals for Topical Use, Antifungals for Dermatological UseCefcapene
go.drugbank.com/drugs/DB13461ExperimentalCategories: Antibacterials for Systemic Use, Antiinfectives for Systemic UseZorubicin
go.drugbank.com/drugs/DB11618ExperimentalZorubicin is a drug of the anthracycline class - a class of medications that have historically demonstrated effective chemotherapy for a variety of cancer types.
Polyacrylamide (crosslinked; 2 mole percent bisacrylamide)
go.drugbank.com/drugs/DB14771InvestigationalPolyacrylamide (crosslinked; 2 mole percent bisacrylamide) is under investigation in clinical trial NCT00629083 (Bulking Agents for the Treatment of Stress Urinary Incontinence in Females).
Disitamab vedotin
go.drugbank.com/drugs/DB17208InvestigationalIt is currently being investigated for cancers.[A254721]
MGN-4893
go.drugbank.com/drugs/DB17338ExperimentalIn February 2011, it was granted FDA orphan designation for the treatment of polycythemia vera.[L47356]